Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel

Table 2 Characteristics associated with WTP (independent sample tests)

Group	Variable		Continuous WTP			Dichotomous WTP
Group	variable	Baseline group	Correlation	Asymptotic Sig.(2-sided test)	Significance	Asymptotic Sig.(2-sided test)	Significance
Demographics	Age (continuous)		− 0.159**	0.000283964	*	0.827600534
	Age (groups)	51–34		0.188791717		0.543239782
	Sex	Male		0.333111573		0.358983071
	Kids	None		0.541079271		0.219903938
	Religion	Jew		0.001961157	**	0.000102976	*
	Religiocity	Secular		0.295683067		0.113728524
	Income	High		0.000206348	*	0.001737942	**
	Education	Academic		0.644694057		0.122174856
Contingent	Health status	Good		0.011310297	***	0.042264041	***
	Health insurance	Basic +		0.043221254	***	0.000999077	*
	Cancer occurrence	Yes		0.147470186		0.053821657
	Cancer type mentioned	No, but other cancer		0.418434382		0.078391950
	Covid vaccination	Yes		0.194654014		0.002670096	**
	Heard about mRNA	Yes		0.425924988		0.011172878	***
	Survival probability	60%		0.113292428		0.097600454
Health	Balanced nutrition	Yes		0.265603967		0.530743299
	Exercise	Yes		0.140479396		0.840145602
	Medical checks	No		0.830881672		0.396679991
	Smoking	No		0.488243685		0.029353168	***
Technology	Technology attitude	Yes		0.000012049	*	0.000000771	*
Technology	Medical innovation attitude	Yes		0.000000002	*	0.000000000	*

ISSN: 2045-4015